In regards to the webcast with questions today, I�

In regards to the webcast with questions today, I’d encourage participants to steer away from questions like, “What’s up with the price movement recently,” “are the shorts in control,” “how does remdesevir compare to leronlimab,” as so on. These questions are a waste of time and pointless to ask as some of the answers are here on the board.

Also, I encourage investors to start asking questions about indications BESIDES COVID19. The COVID19 discussion has nearly been exhausted to the point that we’re basically waiting for trial results, with the Mexico trial, UK and Dr. BP’s paper still pending. Cancer and NASH are potential blockbuster indications that we’ve heard little about recently.

Example good questions:
Has the first person in the NaSH trial been injected? If not, when that milestone expected? How many patients are in the mTNBC trial and how many in the basket trial? When should we expect an update on those patients? Any update on the pre-BTD meeting? Are additional enrollment sites for cancer going to be established to speed up enrollment and expand the reprogram given the past success? Any progress on the Alzheimer’s trial development? What happen to the first patient in the GvHD trial? Have any other patients been enrolled into the GvHD trial?